136 related articles for article (PubMed ID: 35831837)
1. Impact of pectoralis muscle loss on cardiac outcome and survival in Cancer patients who received anthracycline based chemotherapy: retrospective study.
Toama W; Wiederin J; Shanley R; Jewett P; Gu C; Shenoy C; Nijjar PS; Blaes AH
BMC Cancer; 2022 Jul; 22(1):763. PubMed ID: 35831837
[TBL] [Abstract][Full Text] [Related]
2. Pectoralis muscle index might be a factor associated with frailty in older women with breast cancer.
Kızılarslanoğlu MC; Eryılmaz MA; Yortanlı BÇ; Ünal İR; Ünal BC; Baran N; Altunkeser A; Aksoy N
Turk J Med Sci; 2023 Jun; 53(3):824-834. PubMed ID: 37476895
[TBL] [Abstract][Full Text] [Related]
3. CT Attenuation and Cross-sectional-area Index of the Pectoralis Are Associated With Prognosis in Sarcoma Patients.
Jo S; Sebro R
Anticancer Res; 2021 Apr; 41(4):1927-1935. PubMed ID: 33813398
[TBL] [Abstract][Full Text] [Related]
4. Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma.
Telli TA; Bugdayci O; Alan O; Sariyar N; Isik S; Arikan R; Yasar A; Majidova N; Celebi A; Erol B; Ozgen Z; Kostek O; Bayoglu IV; Ercelep O; Dane F; Yumuk PF
Nutr Cancer; 2022; 74(7):2499-2507. PubMed ID: 35416100
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia and anthracycline cardiotoxicity in patients with cancer.
Bas O; Erdemir AG; Onur MR; Ozer N; Sener YZ; Aksu S; Barista I; Guner G; Guven DC; Kertmen N; Aksoy S; Turker A; Dizdar O
BMJ Support Palliat Care; 2023 Dec; 13(4):453-461. PubMed ID: 34479960
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.
Schuler MK; Gerdes S; West A; Richter S; Busemann C; Hentschel L; Lenz F; Kopp HG; Ehninger G; Reichardt P; Pink D
BMC Cancer; 2016 Aug; 16():619. PubMed ID: 27507014
[TBL] [Abstract][Full Text] [Related]
7. Pectoralis muscle area is associated with bone mineral density and lung function in lung transplant candidates.
Parulekar AD; Wang T; Li GW; Hoang V; Kao CC
Osteoporos Int; 2020 Jul; 31(7):1361-1367. PubMed ID: 32170395
[TBL] [Abstract][Full Text] [Related]
8. Determinants of pre-transplantation pectoralis muscle area (PMA) and post-transplantation change in PMA in lung transplant recipients.
Hoang V; Li GW; Kao CC; Dronavalli G; Parulekar AD
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008651
[TBL] [Abstract][Full Text] [Related]
9. Short-Term Changes in Skeletal Muscle Mass After Anthracycline Administration in Adolescent and Young Adult Sarcoma Patients.
Wooten SV; Roth M; Livingston JA; Hildebrandt MAT; Chandra J; Amini B; Kleinerman ES; Gilchrist SC
J Adolesc Young Adult Oncol; 2022 Jun; 11(3):320-322. PubMed ID: 34388045
[TBL] [Abstract][Full Text] [Related]
10. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
Bowles EJ; Wellman R; Feigelson HS; Onitilo AA; Freedman AN; Delate T; Allen LA; Nekhlyudov L; Goddard KA; Davis RL; Habel LA; Yood MU; McCarty C; Magid DJ; Wagner EH;
J Natl Cancer Inst; 2012 Sep; 104(17):1293-305. PubMed ID: 22949432
[TBL] [Abstract][Full Text] [Related]
11. The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicity.
Chia PL; Chiang K; Snyder R; Dowling A
J Oncol Pharm Pract; 2018 Jun; 24(4):264-271. PubMed ID: 29284360
[TBL] [Abstract][Full Text] [Related]
12. Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2-Positive Breast Cancer: A Secondary Analysis of the TRAIN-2 Randomized, Phase 3 Trial.
van der Voort A; van Ramshorst MS; van Werkhoven ED; Mandjes IA; Kemper I; Vulink AJ; Oving IM; Honkoop AH; Tick LW; van de Wouw AJ; Mandigers CM; van Warmerdam LJ; Wesseling J; Vrancken Peeters MT; Linn SC; Sonke GS
JAMA Oncol; 2021 Jul; 7(7):978-984. PubMed ID: 34014249
[TBL] [Abstract][Full Text] [Related]
13. Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy.
Ruddy KJ; Sangaralingham LR; Van Houten H; Nowsheen S; Sandhu N; Moslehi J; Neuman H; Jemal A; Haddad TC; Blaes AH; Villarraga HR; Thompson C; Shah ND; Herrmann J
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005984. PubMed ID: 32106704
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of pneumonia severity score and pectoralis muscle Area on chest CT in adult COVID-19 patients.
Ufuk F; Demirci M; Sagtas E; Akbudak IH; Ugurlu E; Sari T
Eur J Radiol; 2020 Oct; 131():109271. PubMed ID: 32942198
[TBL] [Abstract][Full Text] [Related]
15. Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines.
Peddi P; Master SR; Dwary AD; Ravipati HP; Patel AH; Pasam A; Katikaneni PK; Shi R; Burton GV; Chu QD
Breast J; 2019 Jan; 25(1):62-68. PubMed ID: 30592128
[TBL] [Abstract][Full Text] [Related]
16. Muscle mass loss after neoadjuvant chemotherapy in breast cancer: estimation on breast magnetic resonance imaging using pectoralis muscle area.
Rossi F; Torri L; Lambertini M; De Giorgis S; Calabrese M; Tagliafico AS
Eur Radiol; 2020 Aug; 30(8):4234-4241. PubMed ID: 32232787
[TBL] [Abstract][Full Text] [Related]
17. Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors.
Serrano JM; González I; Del Castillo S; Muñiz J; Morales LJ; Moreno F; Jiménez R; Cristóbal C; Graupner C; Talavera P; Curcio A; Martínez P; Guerra JA; Alonso JJ
Oncologist; 2015 Aug; 20(8):864-72. PubMed ID: 26185196
[TBL] [Abstract][Full Text] [Related]
18. Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.
Brown TR; Vijarnsorn C; Potts J; Milner R; Sandor GG; Fryer C
Pediatr Blood Cancer; 2013 May; 60(5):842-8. PubMed ID: 23382019
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
van Ramshorst MS; van der Voort A; van Werkhoven ED; Mandjes IA; Kemper I; Dezentjé VO; Oving IM; Honkoop AH; Tick LW; van de Wouw AJ; Mandigers CM; van Warmerdam LJ; Wesseling J; Vrancken Peeters MT; Linn SC; Sonke GS;
Lancet Oncol; 2018 Dec; 19(12):1630-1640. PubMed ID: 30413379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
